G. Claesson

Nerve dysfunction following surgical treatment of cervical non‐tuberculous mycobacterial lymphadenitis in children

B. Petrini, M. Eriksson, R. Bennet, 2011, Acta paediatrica.

Long‐term health‐related quality of life in children with lymphatic malformations treated with sclerotherapy generally matched age‐appropriate standardised population norms

K. Boman, T. Wester, G. Claesson, 2018, Acta paediatrica.

Patients with lymphatic malformations who receive the immunostimulant OK‐432 experience excellent long‐term outcomes

B. Petrini, K. Boman, T. Wester, 2015, Acta paediatrica.

OK-432 therapy for lymphatic malformation in 32 patients (28 children).

R. Kuylenstierna, G. Claesson, 2002, International journal of pediatric otorhinolaryngology.

[A revolutionary Japanese method for treatment of lymphangioma].

R. Kuylenstierna, G. Claesson, L. Gordon, 1998, Lakartidningen.

TLR4 preconditioning is associated with low success of OK-432 treatment for lymphatic malformations in children

Adan Chari Jirmo, M. Reismann, T. Wester, 2016, Pediatric Surgery International.

Dynamic Toll-like receptor expression predicts outcome of sclerotherapy for lymphatic malformations with OK-432 in children.

Adan Chari Jirmo, O. Winqvist, M. Reismann, 2014, The Journal of surgical research.

Cystic hygroma: OK-432 is superior to surgery

P. Bretlau, B. Charabi, F. Jensen, 2003 .